The U.S. Army has just published the 2013 edition of its annual Weapon Systems Handbook, which is filled with updated information on dozens of weapon systems, the military contractors who produce them, and the foreign countries that purchase them.
So one learns, for example, that the RQ-11B Raven Small Unmanned Aircraft System is marketed to Denmark, Estonia, Lebanon, and Uganda, while the United States sells artillery ammunition both to Israel and to Lebanon.
An appendix provides an informative breakdown of military industry contractors by weapon system and by the state where the contractor is located.
“The systems listed in this book are not isolated, individual products. Rather, they are part of an integrated Army system of systems designed to equip the Army of the future to successfully face any challenges,” according to the Handbook introduction.
“After 10 years of combat, today’s Army is significantly more capable than the Army of 2001. As we draw down from Iraq and Afghanistan, we must remain flexible, adaptable, and agile enough to respond and meet the needs of the combatant commanders.”
“Our objective is to equip and maintain an Army with the latest most advanced weaponry to win and return home quickly.”
Given the unreliability of private market funding for agricultural biotechnology R&D, substantial federal funding through research programs such as AgARDA is vital for accelerating R&D.
“Given the number of existential crises we must collectively confront, I have found policy entrepreneurship to be a fruitful avenue towards doing some of that work.”
We sit on the verge of another Presidential election – an opportunity for meaningful, science-based policy innovations that can appeal to lawmakers on both sides of the aisle.
Outdated Bureau of Labor Statistics classifications hampers the federal government’s ability to design and implement effective policies for emerging technologies sectors.